Bovie Medical (BVX) Stock Price, News & Analysis

Company Overview

Bovie Medical Corporation was a medical-device company focused on electrosurgical products used by hospitals, physicians and other healthcare providers. Its product portfolio included electrosurgical generators, pencils, electrodes, grounding pads, smoke-evacuation systems and related accessories designed for cutting, coagulation and tissue management during surgical procedures.

The company also developed plasma-based surgical technology through its J-Plasma platform, which was designed to deliver helium plasma for controlled tissue treatment. Bovie Medical marketed its products under the Bovie brand and served customers in the United States and international markets through direct sales and distribution channels.

In 2018, Bovie Medical changed its corporate name to Apyx Medical Corporation as part of a broader focus on its plasma-based technology. The company subsequently traded under the symbol APYX, and Bovie Medical is therefore primarily a historical company name associated with the development and commercialization of electrosurgical and plasma-based medical devices.

Key Stats

• Today's Range: $6.35 to $6.71
• 50-Day Range: $6.48 to $6.48
• 52-Week Range: $2.28 to $7.70
• Volume: 129,500 shs
• Average Volume: 136,878 shs
• Market Capitalization: $215.14 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 11/01/2018
• Today: 10/14/2026

Industry, Sector and Symbol

• Stock Exchange: NYSEAMERICAN
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSEAMERICAN:BVX
• Previous Symbol: AMEX:BVX
• CIK: 719135
• Web: www.boviemedical.com
• Phone: (727) 384-2323
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 33,200,000
• Free Float: N/A
• Market Cap: $215.14 million
• Optionable: Not Optionable
• Beta: N/A